Fennec Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
FENC Nasdaq 2836 fennecpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Fennec Pharmaceuticals Inc.

Positive Signs As Multiple Insiders Buy Fennec Pharmaceuticals Stock - Jan 6th, 2026 3:47 am
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - Dec 26th, 2025 3:44 pm
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors - Dec 9th, 2025 5:00 am
Fennec Pharmaceuticals Reports Positive Top-line Results From Japan Trial - Dec 2nd, 2025 5:56 am
Fennec Pharmaceuticals Says its Phase 2/3 Trial of Pedmark in Japan Meets Primary Endpoint - Dec 2nd, 2025 5:51 am
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss - Dec 2nd, 2025 5:01 am
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference - Nov 26th, 2025 3:59 am
Loss-Making Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Expected To Breakeven In The Medium-Term - Nov 25th, 2025 4:16 am
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption - Nov 19th, 2025 5:03 am
Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada - Nov 18th, 2025 6:30 am
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares - Nov 17th, 2025 2:15 pm
Fennec Pharmaceuticals Prices US$35 Million Share Offering at US$7.50 - Nov 14th, 2025 4:21 am
Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada - Nov 13th, 2025 9:11 pm
Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares - Nov 13th, 2025 9:07 pm
Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue Estimates - Nov 13th, 2025 3:10 pm
Fennec Pharmaceuticals Q3 Loss Narrows as Pedmark Sales Hit Record - Nov 13th, 2025 2:34 pm
Fennec Pharmaceuticals Announces Proposed Offering of Common Shares - Nov 13th, 2025 2:08 pm
Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 13th, 2025 2:01 pm
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates - Nov 12th, 2025 3:25 pm
Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates - Nov 4th, 2025 4:00 pm